Literature DB >> 19740090

The effect of mGlu8 deficiency in animal models of psychiatric diseases.

M Fendt1, H Bürki, S Imobersteg, H van der Putten, K McAllister, J C Leslie, D Shaw, C Hölscher.   

Abstract

The metabotropic glutamate receptor subtype 8 (mGlu(8)) is presynaptically located and regulates the release of the transmitter. Dysfunctions of this mechanism are involved in the pathophysiology of different psychiatric disorders. mGlu(8) deficient mice have been previously investigated in a range of studies, but the results are contradictory and there are still many open questions. Therefore, we tested mGlu(8)-deficient animals in different behavioral tasks that are commonly used in neuropsychiatric research. Our results show a robust contextual fear deficit in mGlu(8)-deficient mice. Furthermore, novel object recognition, chlordiazepoxide-facilitated extinction of operant conditioning and the acoustic startle response were attenuated by mGlu(8) deficiency. We found no changes in sensory processing, locomotor activity, prepulse inhibition, phencyclidine-induced changes in locomotion or prepulse inhibition, operant conditioning, conditioned fear to a discrete cue or in animal models of innate fear and post-traumatic stress disorder. We conclude that mGlu(8) might be a potential target for disorders with pathophysiological changes in brain areas where mGlu(8) modulates glutamate and gamma-amino butyric acid (GABA) transmission. Our data especially point to anxiety disorders involving exaggerated contextual fear, such as generalized anxiety disorders, and to conditions with disturbed declarative memory.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19740090     DOI: 10.1111/j.1601-183X.2009.00532.x

Source DB:  PubMed          Journal:  Genes Brain Behav        ISSN: 1601-183X            Impact factor:   3.449


  17 in total

Review 1.  Genetic models of sensorimotor gating: relevance to neuropsychiatric disorders.

Authors:  Susan B Powell; Martin Weber; Mark A Geyer
Journal:  Curr Top Behav Neurosci       Date:  2012

Review 2.  Group III metabotropic glutamate receptors: pharmacology, physiology and therapeutic potential.

Authors:  Marion S Mercier; David Lodge
Journal:  Neurochem Res       Date:  2014-08-22       Impact factor: 3.996

3.  Acute pharmacological modulation of mGluR8 reduces measures of anxiety.

Authors:  Robert M Duvoisin; Tim Pfankuch; Julie M Wilson; Julie Grabell; Vijay Chhajlani; Dean G Brown; Edwin Johnson; Jacob Raber
Journal:  Behav Brain Res       Date:  2010-04-10       Impact factor: 3.332

4.  mGluR8 modulates excitatory transmission in the bed nucleus of the stria terminalis in a stress-dependent manner.

Authors:  Heather B Gosnell; Yuval Silberman; Brad A Grueter; Robert M Duvoisin; Jacob Raber; Danny G Winder
Journal:  Neuropsychopharmacology       Date:  2011-03-30       Impact factor: 7.853

Review 5.  Fear conditioning, synaptic plasticity and the amygdala: implications for posttraumatic stress disorder.

Authors:  Amy L Mahan; Kerry J Ressler
Journal:  Trends Neurosci       Date:  2011-07-26       Impact factor: 13.837

6.  Opposing roles of mGluR8 in measures of anxiety involving non-social and social challenges.

Authors:  Robert M Duvoisin; Laura Villasana; Matthew J Davis; Danny G Winder; Jacob Raber
Journal:  Behav Brain Res       Date:  2011-03-04       Impact factor: 3.332

7.  Neural substrates for the distinct effects of presynaptic group III metabotropic glutamate receptors on extinction of contextual fear conditioning in mice.

Authors:  Alice Dobi; Simone B Sartori; Daniela Busti; Herman Van der Putten; Nicolas Singewald; Ryuichi Shigemoto; Francesco Ferraguti
Journal:  Neuropharmacology       Date:  2012-05-27       Impact factor: 5.250

8.  The clinical implications of mouse models of enhanced anxiety.

Authors:  Simone B Sartori; Rainer Landgraf; Nicolas Singewald
Journal:  Future Neurol       Date:  2011-07-01

Review 9.  The Role of G Protein-Coupled Receptors (GPCRs) and Calcium Signaling in Schizophrenia. Focus on GPCRs Activated by Neurotransmitters and Chemokines.

Authors:  Tomasz Boczek; Joanna Mackiewicz; Marta Sobolczyk; Julia Wawrzyniak; Malwina Lisek; Bozena Ferenc; Feng Guo; Ludmila Zylinska
Journal:  Cells       Date:  2021-05-17       Impact factor: 6.600

10.  Therapeutic potential of metabotropic glutamate receptor modulators.

Authors:  N Hovelsø; F Sotty; L P Montezinho; P S Pinheiro; K F Herrik; A Mørk
Journal:  Curr Neuropharmacol       Date:  2012-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.